Associated Papers
Sclerosing melanocytic tumors with MAP2K1 in frame deletions and 15q gains: A distinctive pathway of nevogenesis with reproducible morphology.
Friedman BJ et al.
Virchows Archiv : an International Journal of Pathology, 2025
Successful treatment of MAP2K1 mutant stage IV-M1d melanoma with trametinib plus low-dose dabrafenib: a case report.
Dirven I et al.
Frontiers in Medicine, 2024
Intramuscular fast-flow vascular anomaly contains somatic MAP2K1 and KRAS mutations.
Goss JA et al.
Angiogenesis, 2019
Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes.
Lee LH et al.
Jci Insight, 2017
Select a paper to view details